These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24513472)

  • 1. Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation.
    Sardar P; Nairooz R; Chatterjee S; Wetterslev J; Ghosh J; Aronow WS
    Am J Cardiol; 2014 Apr; 113(7):1173-7. PubMed ID: 24513472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation.
    Aryal MR; Ukaigwe A; Pandit A; Karmacharya P; Pradhan R; Mainali NR; Pathak R; Jalota L; Bhandari Y; Donato A
    Am J Cardiol; 2014 Aug; 114(4):577-82. PubMed ID: 24998087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Providência R; Marijon E; Albenque JP; Combes S; Combes N; Jourda F; Hireche H; Morais J; Boveda S
    Europace; 2014 Aug; 16(8):1137-44. PubMed ID: 24550347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis.
    Shurrab M; Morillo CA; Schulman S; Kansal N; Danon A; Newman D; Lashevsky I; Healey JS; Crystal E
    Can J Cardiol; 2013 Oct; 29(10):1203-10. PubMed ID: 23993352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
    Wu S; Yang YM; Zhu J; Wan HB; Wang J; Zhang H; Shao XH
    Am J Cardiol; 2016 Mar; 117(6):926-34. PubMed ID: 26803384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature.
    Hohnloser SH; Camm AJ
    Europace; 2013 Oct; 15(10):1407-11. PubMed ID: 23954917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vanga SR; Santangeli P; Swarup V; Pimentel R; Mansour MC; D'Avila A; Sanchez JE; Burkhardt JD; Chalhoub F; Mohanty P; Coffey J; Shaik N; Monir G; Reddy VY; Ruskin J; Natale A
    J Am Coll Cardiol; 2012 Mar; 59(13):1168-74. PubMed ID: 22305113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RE-CIRCUIT study-randomized evaluation of Dabigatran etexilate compared to warfarin in pulmonary vein ablation: assessment of an uninterrupted periprocedural anticoagulation strategy.
    Calkins H; Gerstenfeld EP; Schilling R; Verma A; Willems S;
    Am J Cardiol; 2015 Jan; 115(1):154-5. PubMed ID: 25456859
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of dabigatran immediately after atrial fibrillation ablation.
    Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):264-8. PubMed ID: 21955008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Bin Abdulhak AA; Khan AR; Tleyjeh IM; Spertus JA; Sanders SU; Steigerwalt KE; Garbati MA; Bahmaid RA; Wimmer AP
    Europace; 2013 Oct; 15(10):1412-20. PubMed ID: 23954918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
    Kaiser DW; Streur MM; Nagarakanti R; Whalen SP; Ellis CR
    J Interv Card Electrophysiol; 2013 Sep; 37(3):241-7. PubMed ID: 23625091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dabigatran in catheter ablation of atrial fibrillation: a call for a randomized control trial.
    Bin Abdulhak AA; Khan AR; Wimmer AP
    Am J Cardiol; 2014 Jun; 113(12):2087-8. PubMed ID: 24878135
    [No Abstract]   [Full Text] [Related]  

  • 15. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
    Kim JS; She F; Jongnarangsin K; Chugh A; Latchamsetty R; Ghanbari H; Crawford T; Suwanagool A; Sinno M; Carrigan T; Kennedy R; Saint-Phard W; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
    Heart Rhythm; 2013 Apr; 10(4):483-9. PubMed ID: 23237911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of uninterrupted dabigatran therapy in patients undergoing ablation for atrial fibrillation.
    Nagao T; Inden Y; Shimano M; Fujita M; Yanagisawa S; Kato H; Ishikawa S; Miyoshi A; Okumura S; Ohguchi S; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Intern Med; 2015; 54(10):1167-73. PubMed ID: 25986252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies.
    Steinberg BA; Hasselblad V; Atwater BD; Bahnson TD; Washam JB; Alexander JH; Daubert JP; Piccini JP
    J Interv Card Electrophysiol; 2013 Sep; 37(3):213-21. PubMed ID: 23881249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Kaseno K; Naito S; Nakamura K; Sakamoto T; Sasaki T; Tsukada N; Hayano M; Nishiuchi S; Fuke E; Miki Y; Nakamura K; Yamashita E; Kumagai K; Oshima S; Tada H
    Circ J; 2012; 76(10):2337-42. PubMed ID: 22785434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home-monitoring of oral anticoagulation vs. dabigatran. An indirect comparison.
    Alonso-Coello P; Zhou Q; Guyatt G
    Thromb Haemost; 2012 Oct; 108(4):647-53. PubMed ID: 22918481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage thrombus with resulting stroke post-RF ablation for atrial fibrillation in a patient on dabigatran.
    Lobo R; McCann C; Hussaini A; Meany TB; Kiernan TJ
    Ir Med J; 2014; 107(10):329-30. PubMed ID: 25551903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.